Rising Mpox Cases in New York: Key Updates and Health Advisory for Physicians
The New York State Department of Health has issued a health advisory noting increased mpox (formerly known as monkeypox) cases, predominantly in Central and Western New York regions. As of May 2022, the global case count exceeds 91,000, with the United States reporting over 31,000 cases. The advisory points out a significant prevalence of mpox among men who have sex with men but advises health professionals to consider mpox in the differential diagnosis of patients presenting with symptoms akin to sexually transmitted infections, irrespective of their gender identity or sexual orientation.
The health advisory highlights the necessity of vaccination, diagnostic testing, appropriate treatment strategies, and updates to prior health alerts. Vaccination, especially with the JYNNEOS vaccine, is strongly advocated for individuals in high-risk categories. The advisory also reinforces the need for clinicians to adhere to stringent infection control protocols and to promptly report any new mpox cases to the local health departments.
Further, the advisory informs healthcare providers about the STOMP study, which investigates Tecovirimat as a treatment option for mpox, and encourages referrals of eligible patients. The document stresses the imperative of maintaining alertness regarding mpox, ensuring timely administration of vaccinations, and providing comprehensive care to those impacted.
